Bank Of America Corp Axsome Therapeutics, Inc. Transaction History

Bank Of America Corp

$1.19 Trillion
Q3 2024

A detailed history of Bank Of America Corp transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 727,528 shares of AXSM stock, worth $60.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

727,528

Previous 890,985 18.35%

Holding current value

$60.1 Million

Previous $71.7 Million 8.86%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $12.9 Million - $15.7 Million	-163,457 Reduced 18.35%	727,528 $65.4 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $46.4 Million - $56.8 Million	705,272 Added 379.76%	890,985 $71.7 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $662,396 - $932,071	9,546 Added 5.42%	185,713 $14.8 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $8.45 Million - $12.3 Million	147,147 Added 507.05%	176,167 $14 Million
Q2 2023 Aug 14, 2023	SELL	$58.41 - $90.35 $205,427 - $317,760	-3,517 Reduced 10.81%	29,020 $2.09 Million
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $76,549 - $98,325	1,311 Added 4.2%	32,537 $2.01 Million
Q4 2022 Feb 10, 2023	SELL	$39.94 - $79.72 $280,498 - $559,873	-7,023 Reduced 18.36%	31,226 $2.41 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $590,194 - $1.14 Million	-16,367 Reduced 29.97%	38,249 $1.71 Million
Q2 2022 Aug 12, 2022	BUY	$21.74 - $46.75 $202,095 - $434,588	9,296 Added 20.51%	54,616 $2.09 Million
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $201,355 - $351,649	8,496 Added 23.07%	45,320 $1.88 Million
Q4 2021 Feb 08, 2022	SELL	$30.7 - $43.36 $104,073 - $146,990	-3,390 Reduced 8.43%	36,824 $1.39 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $221,658 - $759,938	11,133 Added 38.28%	40,214 $1.33 Million
Q2 2021 Sep 13, 2021	BUY	$50.63 - $73.5 $1.47 Million - $2.14 Million	29,081 New	29,081 $1.96 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.54B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Axsome Therapeutics, Inc. Transaction History